These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36092880)

  • 81. Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma.
    Liu B; Pang K; Feng C; Liu Z; Li C; Zhang H; Liu P; Li Z; He S; Tu C
    Front Genet; 2022; 13():1063057. PubMed ID: 36568384
    [No Abstract]   [Full Text] [Related]  

  • 82. Effect of m
    Wang J; Zhang C; He W; Gou X
    Front Oncol; 2020; 10():3. PubMed ID: 32038982
    [No Abstract]   [Full Text] [Related]  

  • 83. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Construction of a 13-Gene Signature as a Novel Prognostic Marker for Patients with Clear Cell Renal Cell Carcinoma and the Role of XCR1 in Cell Proliferation.
    Yuan B; Li F; Li Y; Chen Y
    Cancer Manag Res; 2020; 12():4017-4027. PubMed ID: 33116819
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
    Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
    Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma.
    Li YJ; Li HY; Zhang Q; Wei SL
    Front Genet; 2022; 13():942785. PubMed ID: 35942287
    [No Abstract]   [Full Text] [Related]  

  • 87. Identification of Hub Genes Associated With Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis.
    Huang H; Zhu L; Huang C; Dong Y; Fan L; Tao L; Peng Z; Xiang R
    Front Oncol; 2021; 11():726655. PubMed ID: 34660292
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Identification of a four immune-related genes signature based on an immunogenomic landscape analysis of clear cell renal cell carcinoma.
    Gao X; Yang J; Chen Y
    J Cell Physiol; 2020 Dec; 235(12):9834-9850. PubMed ID: 32452055
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Identification of cuproptosis-related patterns and construction of a scoring system for predicting prognosis, tumor microenvironment-infiltration characteristics, and immunotherapy efficacy in breast cancer.
    Li W; Zhang X; Chen Y; Pang D
    Front Oncol; 2022; 12():966511. PubMed ID: 36212436
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A Novel Nine Apoptosis-Related Genes Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma and its Associations with Immune Infiltration.
    Wang Y; Chen Y; Zhu B; Ma L; Xing Q
    Front Mol Biosci; 2021; 8():567730. PubMed ID: 33748185
    [No Abstract]   [Full Text] [Related]  

  • 91. Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma.
    Chang K; Yuan C; Liu X
    Front Oncol; 2021; 11():649347. PubMed ID: 33996565
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A novel defined cuproptosis-related gene signature for predicting the prognosis of lung adenocarcinoma.
    Zhang H; Shi Y; Yi Q; Wang C; Xia Q; Zhang Y; Jiang W; Qi J
    Front Genet; 2022; 13():975185. PubMed ID: 36046242
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
    Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
    Front Oncol; 2022; 12():938679. PubMed ID: 35982954
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cuproptosis identifies respiratory subtype of renal cancer that confers favorable prognosis.
    Li K; Tan L; Li Y; Lyu Y; Zheng X; Jiang H; Zhang X; Wen H; Feng C
    Apoptosis; 2022 Dec; 27(11-12):1004-1014. PubMed ID: 36103026
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma.
    Chen J; Zhan Y; Zhang R; Chen B; Huang J; Li C; Zhang W; Wang Y; Gao Y; Zheng J; Li Y
    Front Oncol; 2021; 11():700084. PubMed ID: 34249761
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma.
    Xin S; Mao J; Cui K; Li Q; Chen L; Li Q; Tu B; Liu X; Wang T; Wang S; Liu J; Song X; Song W
    Front Mol Biosci; 2022; 9():974722. PubMed ID: 36188220
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Identification of molecular subtypes and a six-gene risk model related to cuproptosis for triple negative breast cancer.
    Zhu B; Wang S; Wang R; Wang X
    Front Genet; 2022; 13():1022236. PubMed ID: 36386788
    [No Abstract]   [Full Text] [Related]  

  • 98. Identification of an individualized autophagy prognostic index in clear cell renal cell carcinoma patients.
    Jin Y; Li F; Guo P; Dong K; Guo P; Wang H; Chen Y; Wang Z
    Transl Cancer Res; 2020 Apr; 9(4):2951-2961. PubMed ID: 35117651
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
    Qu G; Wang H; Yan H; Liu G; Wu M
    Front Oncol; 2022; 12():857619. PubMed ID: 35296026
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy.
    Wang XX; Wu LH; Ji H; Liu QQ; Deng SZ; Dou QY; Ai L; Pan W; Zhang HM
    Front Mol Biosci; 2022; 9():1001788. PubMed ID: 36250008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.